Wearable Injectors Market Research Report – Forecast to 2027

Wearable Injectors Market Research Report: By Type (On-Body, Off-Body, Hand Held), by Usage (Disposable, Semi-Reusable), by Mechanism of Injection (Spring Based, Others), by Therapeutic Area (Oncology, Diabetes, Others), by End-User– Forecast Till 2027

ID: MRFR/MED/5029-HCR | February 2021 | Region: Global | 100 pages

Wearable Injectors Market Scenario


The wearable injectors market is expected to grow significantly over the forecast period. It is estimated that the wearable injectors market is expected to register a CAGR of ~ 15.2% during the forecast period from 2018 to 2023. Wearable Injectors are medical devices designed to dispense large doses of the drug. Wearable Injectors are user-friendly, convenient and they lessen the need for multiple painful injections.


Numerous factors such as growing demand of convenient methods of drug administration, rising prevalence of chronic diseases such as diabetes, technological advancements and design development in wearable injectors are expected to drive the growth of the market. For instance, in July 2016, Amgen received US Food and Drug Administration (FDA) approval for its on-body wearable injector, Repatha (evolocumab) Pushtronex system, a human monoclonal antibody injector.


Moreover, favorable healthcare investments by government and the rising demand for minimally invasive devices boosts the growth of the market. However, stringent government regulation for product approval and the growing preference for traditional methods of drug delivery may hamper the market growth during the assessment period.


Segmentation


The wearable injectors market has been segmented into type, usage, mechanism of action, therapeutic area, and end-user.


The market, on the basis of type, has been segmented into on-body wearable injectors, off-body wearable injectors, and hand-held wearable injectors.


The market, by usage, has been segmented into disposable and semi-reusable.


The market, by mechanism of action, has been segmented into spring based, motor driven, rotary pump, expanding battery, pressurized gas, and collapsible reservoir.


The market, by therapeutic area, has been segmented into oncology, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes, and others.


The market, by end-user, has been segmented into hospitals, clinics, homecare, ambulatory surgery centers, others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The wearable injectors market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European wearable injectors market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The wearable injectors market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The wearable injectors market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key players


West Pharmaceutical Services, Inc., Valeritas, Inc., Eli Lilly and Company, YPSOMED, Amgen Inc., Becton, Dickinson and Company (BD), CeQur SA, SteadyMed Therapeutics, Inc., BioSpace, Enable Injections, and Sensile Medical AG are some of the key players in the global wearable injectors market.


Regional Market Summary


Global Wearable Injectors Market Share (%), by Region, 2017


Wearable Injectors Market Share


Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)


Geographically, the Americas is anticipated to dominate the global wearable injectors market owing to a well-developed healthcare sector, rising prevalence of autoimmune and chronic disease and growing healthcare expenditure. According to a report published by American Autoimmune Related Diseases Association (AARDA) in April 2017, in the US approximately 50 million people i.e. nearly 20% population suffer from autoimmune diseases. Additionally, government funding in this region contributes to the growth of the market.


Europe is expected to hold the second largest position in the global wearable injectors market. The market growth in this region is attributed to the growing prevalence of chronic diseases, the availability of funds for research, and increasing healthcare expenditure. According to a report published by the NSD Alliance in July 2017, 1/3rd of the European population above the age of 15 years suffer from a chronic disease.


Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, rising prevalence of chronic diseases like diabetes, cardiovascular diseases and increasing government funding for the healthcare sector. According to a study published in the Asian Pacific Journal of Tropical Biomedicine journal in 2014, it was estimated that about 150 million diabetic patients reside within the region, out of which more than 95% have type 2 diabetes mellitus.


On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.


Wearable Injectors Market, by Type



  • On-Body Wearable Injectors

  • Off-Body Wearable Injectors

  • Hand Held Wearable Injectors


Wearable Injectors Market, by Usage



  • Disposable Wearable Injectors

  • Semi-Reusable Wearable Injectors


Wearable Injectors Market, by Mechanism of Action



  • Spring Based

  • Motor Driven

  • Rotary Pump

  • Expanding Battery

  • Pressurized Gas

  • Collapsible Reservoirs


Wearable Injectors Market, by Therapeutic Area



  • Oncology

  • Infectious Diseases

  • Cardiovascular Diseases

  • Autoimmune Diseases

  • Diabetes

  • Others


Wearable Injectors Market, by End User



  • Hospitals

  • Clinics

  • Home Care

  • Ambulatory Surgery Centers

  • Others


Wearable Injectors Market, by Region



  • Americas





    • North America

    • US

    • Canada

    • South America





  • Europe





    • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • UK

    • Rest of Western Europe

    • Eastern Europe





  • Asia-Pacific





    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa





    • Middle East

    • Africa 




Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institute

  • Academic Institutes and Universities



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   15.2% (2018-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Usage, Mechanism of action, Therapeutic Area, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   West Pharmaceutical Services, Inc., Valeritas, Inc., Eli Lilly and Company, YPSOMED, Amgen Inc., Becton, Dickinson and Company (BD), CeQur SA, SteadyMed Therapeutics, Inc., BioSpace, Enable Injections, and Sensile Medical AG
  Key Market Opportunities

  • Technological advancements
  • Design development in wearable injectors
  •   Key Market Drivers

  • Growing demand of convenient methods of drug administration
  • Rising prevalence of chronic diseases


  • Frequently Asked Questions (FAQ) :


    Wearable Injectors are medical devices designed to dispense large doses of the drug. Wearable Injectors are user-friendly, convenient and they lessen the need for multiple painful injections.

    Wearable injectors are used to subcutaneously administer insulin and other drugs that require large dose volumes and extended delivery period.

    Global market for the Wearable Injectors would record growth of the 15.2% CAGR during the forecast period covering 2018 to 2023.

    Factors like convenient methods of drug administration, increasing chronic diseases such as diabetes, better inclusion of advanced technologies, and improved design development in wearable injectors can trigger growth for the Wearable Injectors Market.

    Strict government measures and growing resurfacing of traditional methods can hold back the Wearable Injectors Market growth.

    Oncology, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes, and others are the therapeutic areas for the global Wearable Injectors Market.

    Americas is the regional Wearable Injectors Market with the maximum market share.

    Table of Contents:

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary Research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restraints

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Wearable Injectors Market, by Type

    6.1 Introduction

    6.2 On-Body Wearable Injectors

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.3 Off-Body Wearable Injectors

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    6.4 Hand Held Wearable Injectors

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 7. Global Wearable Injectors Market, by Usage

    7.1 Introduction

    7.2 Disposable

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    7.3 Semi-Reusable

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 8. Global Wearable Injectors Market, by Mechanism of Injection

    8.1 Introduction

    8.2 Spring Based

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.3 Motor Driven

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.4 Rotary Pump

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.5 Expanding Battery

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.6 Pressurized Gas

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    8.7 Collapsible Reservoir

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    Chapter 9. Global Wearable Injectors Market, by Therapeutic Area

    9.1 Introduction

    9.2 Oncology

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.3 Infectious Diseases

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.4 Cardiovascular Diseases

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.5 Autoimmune Diseases

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.6 Diabetes

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    9.7 Others

    Chapter 10. Global Wearable Injectors Market, by End-User

    10.1 Introduction

    10.2 Hospitals

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10.3 Clinics

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10.4 Home Care

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10.5 Ambulatory Surgery Centers

    Market Estimates & Forecast, by Region, 2020-2027

    Market Estimates & Forecast, by Country, 2020-2027

    10.6 Others

    Chapter 11. Global Wearable Injectors Market, by Region

    11.1 Introduction

    11.2 Americas

    11.2.1 North America

    11.2.1.1 US

    11.2.1.2 Canada

    11.2.2 South America

    11.3 Europe

    11.3.1 Western Europe

    11.3.1.1 Germany

    11.3.1.2 France

    11.3.1.3 Italy

    11.3.1.4 Spain

    11.3.1.5 UK

    11.3.1.6 Rest of Western Europe

    11.3.2 Eastern Europe

    11.4 Asia-Pacific

    11.4.1 Japan

    11.4.2 China

    11.4.3 India

    11.4.4 Australia

    11.4.5 South Korea

    11.4.6 Rest of Asia-Pacific

    11.5 Middle East & Africa

    11.5.1 Middle East

    11.5.2 Africa

    Chapter 12. Company Landscape

    12.1 Introduction

    12.2 Market Share Analysis

    12.3 Key Development & Strategies

    Chapter 13. Company Profiles

    13.1 West Pharmaceutical Services, Inc.

    13.1.1 Company Overview

    13.1.2 Product Overview

    13.1.3 Financials Overview

    13.1.4 Key Developments

    13.1.5 SWOT Analysis

    13.2 Valeritas, Inc.

    13.2.1 Company Overview

    13.2.2 Product Overview

    13.2.3 Financial Overview

    13.2.4 Key Developments

    13.2.5 SWOT Analysis

    13.3 Eli Lily and Company

    13.3.1 Company Overview

    13.3.2 Product Overview

    13.3.3 Financial Overview

    13.3.4 Key Development

    13.3.5 SWOT Analysis

    13.4 YPSOMED

    13.4.1 Company Overview

    13.4.2 Product Overview

    13.4.3 Financial Overview

    13.4.4 Key Development

    13.4.5 SWOT Analysis

    13.5 Amgen, Inc.

    13.5.1 Company Overview

    13.5.2 Product Overview

    13.5.3 Financial overview

    13.5.4 Key Developments

    13.5.5 SWOT Analysis

    13.6 Becton, Dickinson and Company (BD)

    13.6.1 Company Overview

    13.6.2 Product Overview

    13.6.3 Financial Overview

    13.6.4 Key Developments

    13.6.5 SWOT Analysis

    13.7 CeQur SA

    13.7.1 Overview

    13.7.2 Product Overview

    13.7.3 Financial Overview

    13.7.4 Key Developments

    13.7.5 SWOT Analysis

    13.8 SteadyMed Therapeutics, Inc.

    13.8.1 Overview

    13.8.2 Product Overview

    13.8.3 Financials

    13.8.4 Key Developments

    13.8.5 SWOT Analysis

    13.9 BioSpace

    13.9.1 Overview

    13.9.2 Product Overview

    13.9.3 Financials

    13.9.4 Key Developments

    13.9.5 SWOT Analysis

    13.10 Enable Injections

    13.10.1 Overview

    13.10.2 Product Overview

    13.10.3 Financials

    13.10.4 Key Developments

    13.10.5 SWOT Analysis

    13.11 Sensile Medical AG

    13.11.1 Overview

    13.11.2 Product Overview

    13.11.3 Financials

    13.11.4 Key Developments

    13.11.5 SWOT Analysis

    Chapter 14 MRFR Conclusion

    14.1 Key Findings

    14.1.1 From CEO’s Viewpoint

    14.1.2 Unmet Needs of the Market

    14.2 Key Companies to Watch

    14.3 Predictions for the Wearable Injectors Industry

    Chapter 15. Appendix


    LIST OF TABLES

    Table 1 Global Wearable Injectors Market Synopsis, 2020-2027

    Table 2 Global Wearable Injectors Market Estimates and Forecast, 2020-2027 (USD Million)

    Table 3 Global Wearable Injectors Market, by Region, 2020-2027 (USD Million)

    Table 4 Global Wearable Injectors Market, by Type, 2020-2027 (USD Million)

    Table 5 Global Wearable Injectors Market, by Usage, 2020-2027(USD Million)

    Table 6 Global Wearable Injectors Market, by Mechanism of Action, 2020-2027 (USD Million)

    Table 7 Global Wearable Injectors Market, by Therapeutic Area, 2020-2027(USD Million)

    Table 8 Global Wearable Injectors Market, by End-User, 2020-2027 (USD Million)

    Table 9 North America: Wearable Injectors Market, by Type, 2020-2027 (USD Million)

    Table 10 North America: Wearable Injectors Market, by Usage, 2020-2027 (USD Million)

    Table 11 North America: Wearable Injectors Market, by Mechanism of Action, 2020-2027 (USD Million)

    Table 12 North America: Wearable Injectors Market, by Therapeutic Area, 2020-2027 (USD Million)

    Table 13 North America: Wearable Injectors Market, by End-User, 2020-2027 (USD Million)

    Table 14 US: Wearable Injectors Market, by Type, 2020-2027 (USD Million)

    Table 15 US: Wearable Injectors Market, by Usage, 2020-2027 (USD Million)

    Table 16 US: Wearable Injectors Market, by Mechanism of Action, 2020-2027 (USD Million)

    Table 17 US: Wearable Injectors Market, by Therapeutic Area, 2020-2027 (USD Million)

    Table 18 US: Wearable Injectors Market, by End-User, 2020-2027 (USD Million)

    Table 19 Canada: Wearable Injectors Market, by Type, 2020-2027 (USD Million)

    Table 20 Canada: Wearable Injectors Market, by Usage, 2020-2027 (USD Million)

    Table 21 Canada: Wearable Injectors Market, by Mechanism of Action, 2020-2027 (USD Million)

    Table 22 Canada: Wearable Injectors Market, by Therapeutic Area, 2020-2027 (USD Million)

    Table 23 Canada: Wearable Injectors Market, by End-User, 2020-2027 (USD Million)

    Table 24 South America: Wearable Injectors Market, by Type, 2020-2027 (USD Million)

    Table 25 South America: Wearable Injectors Market, by Usage, 2020-2027 (USD Million)

    Table 26 South America: Wearable Injectors Market, by Mechanism of Action, 2020-2027 (USD Million)

    Table 27 South America: Wearable Injectors Market, by Therapeutic Area, 2020-2027 (USD Million)

    Table 28 South America: Wearable Injectors Market, by End-User, 2020-2027 (USD Million)

    Table 29 Europe: Wearable Injectors Market, by Type, 2020-2027 (USD Million)

    Table 30 Europe: Wearable Injectors Market, by Usage, 2020-2027 (USD Million)

    Table 31 Europe: Wearable Injectors Market, by Mechanism of Action, 2020-2027 (USD Million)

    Table 32 Europe: Wearable Injectors Market, by Therapeutic Area, 2020-2027 (USD Million)

    Table 33 Europe: Wearable Injectors Market, by End-User, 2020-2027 (USD Million)

    Table 34 Western Europe: Wearable Injectors Market, by Type, 2020-2027 (USD Million)

    Table 35 Western Europe: Wearable Injectors Market, by Usage, 2020-2027 (USD Million)

    Table 36 Western Europe: Wearable Injectors Market, by Mechanism of Action, 2020-2027 (USD

    Million)

    Table 37 Western Europe: Wearable Injectors Market, by Therapeutic Area, 2020-2027 (USD Million)

    Table 38 Western Europe: Wearable Injectors Market, by End-User, 2020-2027 (USD

    Million)

    Table 39 Eastern Europe: Wearable Injectors Market, by Type, 2020-2027 (USD Million)

    Table 40 Eastern Europe: Wearable Injectors Market, by Usage, 2020-2027 (USD Million)

    Table 41 Eastern Europe: Wearable Injectors Market, by Mechanism of Action, 2020-2027 (USD Million)

    Table 42 Eastern Europe: Wearable Injectors Market, by Therapeutic Area, 2020-2027 (USD Million)

    Table 43 Eastern Europe: Wearable Injectors Market, by End-User, 2020-2027 (USD Million)

    Table 44 Asia-Pacific: Wearable Injectors Market, by Type, 2020-2027 (USD Million)

    Table 45 Asia-Pacific: Wearable Injectors Market, by Usage, 2020-2027 (USD Million)

    Table 46 Asia-Pacific: Wearable Injectors Market, by Mechanism of Action, 2020-2027 (USD Million)

    Table 47 Asia-Pacific: Wearable Injectors Market, by Therapeutic Area, 2020-2027 (USD Million)

    Table 48 Asia-Pacific: Wearable Injectors Market, by End-User, 2020-2027 (USD Million)

    Table 49 Middle East & Africa: Wearable Injectors Market, by Type, 2020-2027 (USD Million)

    Table 50 Middle East & Africa: Wearable Injectors Market, by Usage, 2020-2027 (USD Million)

    Table 51 Middle East & Africa: Wearable Injectors Market, by Mechanism of Action, 2020-2027 (USD Million)

    Table 52 Middle East & Africa: Wearable Injectors Market, by Therapeutic Area, 2020-2027 (USD Million)

    Table 53 Middle East & Africa: Wearable Injectors Market, by End-User, 2020-2027 (USD Million)


    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Wearable Injectors Market

    Figure 3 Segmentation Market Dynamics for Global Wearable Injectors Market

    Figure 4 Global Wearable Injectors Market Share, by Type, 2020

    Figure 5 Global Wearable Injectors Market Share, by Usage, 2020

    Figure 6 Global Wearable Injectors Market Share, by Mechanism of Action, 2020

    Figure 5 Global Wearable Injectors Market Share, by Therapeutic Area, 2020

    Figure 6 Global Wearable Injectors Market Share, by End User, 2020

    Figure 7 Global Wearable Injectors Market Share, by Region, 2020

    Figure 8 North America: Wearable Injectors Market Share, by Country, 2020

    Figure 9 Europe: Wearable Injectors Market Share, by Country, 2020

    Figure 10 Asia-Pacific: Wearable Injectors Market Share, by Country, 2020

    Figure 11 Middle East & Africa: Wearable Injectors Market Share, by Country, 2020

    Figure 12 Global Wearable Injectors Market: Company Share Analysis, 2020 (%)

    Figure 13 West Pharmaceutical Services, Inc.: Key Financials

    Figure 14 West Pharmaceutical Services, Inc.: Segmental Revenue

    Figure 15 West Pharmaceutical Services, Inc.: Geographical Revenue

    Figure 16 Valeritas Inc.: Key Financials

    Figure 17 Valeritas Inc.: Segmental Revenue

    Figure 18 Valeritas Inc.: Geographical Revenue

    Figure 19 Eli Lilly and Company: Key Financials

    Figure 20 Eli Lilly and Company: Segmental Revenue

    Figure 21 Eli Lilly and Company: Geographical Revenue

    Figure 22 YPSOMED: Key Financials

    Figure 23 YPSOMED: Segmental Revenue

    Figure 24 YPSOMED: Geographical Revenue

    Figure 25 Amgen, Inc.: Key Financials

    Figure 26 Amgen, Inc.: Segmental Revenue

    Figure 27 Amgen, Inc.: Geographical Revenue

    Figure 28 Becton, Dickinson and Company (BD): Key Financials

    Figure 29 Becton, Dickinson and Company (BD): Segmental Revenue

    Figure 30 Becton, Dickinson and Company (BD): Geographical Revenue

    Figure 31 CeQur SA: Key Financials

    Figure 32 CeQur SA: Segmental Revenue

    Figure 33 CeQur SA: Geographical Revenue

    Figure 34 SteadyMed Therapeutics, Inc.: Key Financials

    Figure 35 SteadyMed Therapeutics, Inc.: Segmental Revenue

    Figure 36 SteadyMed Therapeutics, Inc.: Geographical Revenue

    Figure 37 BioSpace: Key Financials

    Figure 38 BioSpace: Segmental Revenue

    Figure 39 BioSpace: Geographical Revenue

    Figure 40 Enable Injections: Key Financials

    Figure 41 Enable Injections: Segmental Revenue

    Figure 42 Enable Injections: Geographical Revenue

    Figure 43 Sensile Medical AG: Key Financials

    Figure 44 Sensile Medical AG: Segmental Revenue

    Figure 45 Sensile Medical AG: Geographical Revenue